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Background: Cardiac Allograft Vasculopathy (CAV) limits long term survival after heart transplantation. We evaluated the diagnostic accuracy 
of Coronary Computed Tomography Angiography (CCTA) for detecting CAV compared with Conventional Coronary Angiography (CCAG) alone or with 
Intravascular Ultrasound (IVUS).
Methods: A systematic review of Medline, Cochrane, and Embase for all prospective trials was performed with standard meta-analysis approach for 
diagnostic test and bivariate analysis. Thirteen studies evaluating 615 patients (mean age 52 years, 83% males) and 9,481 segments were included.
results: Patient-based analyses comparing CCTA vs. CCAG for detection of any CAV (> luminal irregularities) and significant CAV (stenosis ≥ 50%), 
showed mean weighted sensitivities of 97% and 94%, specificities of 81% and 92%, negative predictive value (NPV) of 97% and 99%, positive 
predictive value (PPV) of 78% and 67%, and diagnostic accuracies of 88% and 94%, respectively. There was a strong trend towards improved 
sensitivity (97% vs. 91%, p=0.06) and NPV (99% vs. 97%, p=0.06) to detect significant CAV with 64-slice vs. 16-slice CCTA. Analysis of 64-slice CCTA 
vs. IVUS showed a mean weighted sensitivity and specificity of 81% and 75% to detect CAV (intimal thickening > 0.5 mm), whereas PPV and NPV 
were 93% and 50%, respectively.
conclusion: CCTA is a reliable noninvasive modality with excellent sensitivity, specificity and NPV. CCTA as a screening tool for CAV is feasible for 
heart transplant recipients. 
